본문 바로가기
KERD
논문KCI 등재

중의학 논문에 나타난 유방암의 연구 동향에 대한 고찰 - 중의학 논문을 중심으로 -

Recent Studies of Breast Cancer in Traditional Chinese Medicine Journals

윤성우|박재우|정종수|정의민|정현식
대한한방부인과학회 (The Society Of Oriental Obstetrics & Gynecology)|2009.02|대한한방부인과학회지 (The Journal of Oriental Obstetrics ＆ Gynecology)|제22권 제1호|pp. 263-278

1

조회

0

다운로드

7

인용

0

참고문헌

키워드

Breast cancerTraditional chinese medicine (TCM)
주제분류한의학

초록

Purpose: The purpose of this study is to research trends in the study of breast cancer in Traditional Chinese Medicine (TCM) and to establish the further direction for its study. Methods: We reviewed TCM papers published in the last 29 years (1979-2008). Results: 1. We researched 49 papers and the patterns of study were as follows: in vitro studies were 27 papers (55.1%), in vivo studies were 9 papers (18.4%) and clinical studies were 19 papers (38.8%). 2. In vitro studies on breast cancer research in TCM were focused on cytotoxicity (17 papers) and apoptosis (8 papers). Most of in vivo studies (6 papers) were done for the purpose of inducing growth suppression of tumor cell after administration of the test drug. Each drug acted on this effect through various types of mechanism. 3. Unlike in vitro and in vivo studies, clinical studies on growth suppression of tumor cell were rare (4 papers). Most of the studies were focused on reduction of side effect of chemotherapy or synergistic effect with chemotherapy (7 papers), immune regulation (7 papers), and improvement of quality of life (6 papers). 4. Among the treatment method we reviewed, 'Runing Ⅱ(乳宁Ⅱ號方)' was the only medication that further studied as clinical trial after experimental study. 5. Since almost all studies have defects like poorly designed model or insufficient data description, it was difficult to make any definite conclusion about these studies. Conclusion: More subsequent clinical studies based on experimental study will be needed afterwards. Strict and high-level study design with detailed description will be needed in further study.

Abstract

Purpose: The purpose of this study is to research trends in the study of breast cancer in Traditional Chinese Medicine (TCM) and to establish the further direction for its study. Methods: We reviewed TCM papers published in the last 29 years (1979-2008). Results: 1. We researched 49 papers and the patterns of study were as follows: in vitro studies were 27 papers (55.1%), in vivo studies were 9 papers (18.4%) and clinical studies were 19 papers (38.8%). 2. In vitro studies on breast cancer research in TCM were focused on cytotoxicity (17 papers) and apoptosis (8 papers). Most of in vivo studies (6 papers) were done for the purpose of inducing growth suppression of tumor cell after administration of the test drug. Each drug acted on this effect through various types of mechanism. 3. Unlike in vitro and in vivo studies, clinical studies on growth suppression of tumor cell were rare (4 papers). Most of the studies were focused on reduction of side effect of chemotherapy or synergistic effect with chemotherapy (7 papers), immune regulation (7 papers), and improvement of quality of life (6 papers). 4. Among the treatment method we reviewed, 'Runing Ⅱ(乳宁Ⅱ號方)' was the only medication that further studied as clinical trial after experimental study. 5. Since almost all studies have defects like poorly designed model or insufficient data description, it was difficult to make any definite conclusion about these studies. Conclusion: More subsequent clinical studies based on experimental study will be needed afterwards. Strict and high-level study design with detailed description will be needed in further study.

참고문헌 (65)

  1. Parkin DM, "Global cancer statistics 2002", CA Cancer J Clin, 55(2), pp.74~108 (2005)
  2. Korea Central Cancer Registry, "2002 Annual Report of the Korea Central Cancer Registry" (2003), Ministry of Health and Welfare
  3. Anthony SF, "Harrison's Principals of Internal Medicine, 17th Edition" (2008), McGraw-Hill Medical
  4. Ries LAG, "SEER Cancer Statistics Review 1975-2005" (2008), National Cancer Institute
  5. Gerber B, "Complementary and alternative therapeutic approaches in patients with early breast cancer: a systematic review", Breast Cancer Res Treat, 95(3), pp.199~209 (2006)
  6. 韩月恒, "水飞蓟素对乳腺癌细胞系的作用及其机制研究", 中草药, 34(3), pp.238~241 (2003)
  7. 张晓丽, "延胡索乙素逆转多药耐药性人乳腺癌细胞MCF-7", 中药药理与临床, 21(6), pp.19~21 (2005)
  8. 高志捷, "蓣皂苷体外抑制肿瘤细胞增殖的研究", 中国中医药信息杂志, 12(7), pp.33~34 (2005)
  9. 张静, "香加皮乙酸乙酯提取物诱导人乳腺癌MCF-7细胞凋亡的研究", 肿瘤, 26(5), pp.418~421 (2006)
  10. 陈晓蕾, "秦皮醇提取物体外抗乳腺癌细胞增殖的研究", 中国药房, 18(15), pp.1124~1127 (2007)
  11. 尹春萍, "红三叶总异黄酮对人乳腺癌MCF-7细胞增殖和凋亡的影响", 中草药, 38(2), pp.232~234 (2007)
  12. 刘东颖, "虫夏草对乳腺癌细胞凋亡的诱导及相关基因表达的调控", 天津医科大学学报, 13(2), pp.206~209 (2007)
  13. 刘东颖, "虫夏草诱导乳癌细胞MCF- 7凋亡的实验研究", 河北中医, 29(1), pp.66~68 (2007)
  14. 尹春萍, "猫爪草皂苷抑制乳腺癌的机制研究", 中国医院药学杂志, 28(2), pp.93~96 (2008)
  15. 河福金, "金雀黄素和大豆黄酮对人乳腺癌细胞系体外增殖作用的影响", 北京中医药大学学报, 25(1), pp.22~25 (2002)
  16. 吴雪卿, "中药乳宁Ⅱ号对人乳腺癌MCF-7细胞株体内外生长的影响", 中国中医药科技, 7(4), pp.211~212 (2000)
  17. 韩炯, "葡萄籽提取物原花青素诱导乳腺癌MCF-7细胞脱落凋亡", 中草药, 34(8), pp.722~725 (2003)
  18. 张文卿, "中药R1对耐阿霉素人乳腺癌细胞系（MCF7adr）多药耐受的逆转作用", 中药药理与临床, 5, pp.16~21 (1994)
  19. 郭伟剑, "康莱特诱导具多药耐药表型的人乳腺癌细胞MCF7adr凋亡及周期阻滞的研究", 中国中西医结合杂志, 21, pp.123~125 (2001)
  20. 河福金, "金雀异黄素对人乳腺癌细胞体外生长的抑制作用", 中国中药杂志, 27(12), pp.936~939 (2002)
  21. 宋士一, "大蒜成分DADS抑制人类乳腺癌细胞MDA-MB-231的恶性表型及环氧化酶-2的基因表达", 实用癌症杂志, 22(1), pp.9~12 (2007)
  22. 朱国旗, "黄芩苷诱导人乳腺癌细胞株MDA-MB-231凋亡作用的研究", 安徽中医学院学报, 27(2), pp.20~23 (2008)
  23. 朱晓音, "当归提取物对PC3、HeLa、MDA-MB-435肿瘤细胞增殖的影响", 山东中医杂志, 26(11), pp.776~778 (2007)
  24. 戚玮琳, "红景天抑制乳腺癌血管新生的作用及其机制", 上海中医药杂志, 41(7), pp.62~65 (2007)
  25. 阙华发, "乳宁Ⅱ号对人乳腺癌MDA- MB-435细胞株生长转移的影响", 中国中医基础医学杂志, 8(7), pp.32~34 (2002)
  26. 朱君荣, "人参皂苷-Rh_2对人乳腺癌T47D细胞的生长抑制作用及对Caspase-3表达的影响", 中国临床药理学与治疗学, 12(6), pp.630~634 (2007)
  27. 赵丕文, "异补骨脂素和蜕皮甾酮对人乳腺癌T47D细胞增殖及ER亚型表达的影响", 北京中医药大学学报, 30(4), pp.242~245 (2007)
  28. 孙斌, "蒺藜皂苷对乳腺癌细胞Bcap-37的体外抑制作用", 中药材, 26(2), pp.104~106 (2003)
  29. 冯正权, "安体优主要成分体外抑制BCAP37细胞生长的实验研究", 浙江中医学院学报, 27(5), pp.53~54 (2003)
  30. 章平, "沙棘籽渣黄酮诱导人乳腺癌细胞凋亡相关基因的表达谱变化", 癌症, 24(4), pp.454~460 (2005)
  31. 徐贵发, "麦胚黄酮类提取物对人乳腺癌细胞BCap-37的体外抑制作用", 卫生研究, 28(3), pp.151~152 (1999)
  32. 赵秀兰, "Genistein对人乳腺癌细胞株BCaP-37的体外抑制作用", 山东大学学报(医学版), 40(4), pp.373~375 (2002)
  33. 薛美兰, "牛磺酸抑制二甲基苯蒽诱发大鼠乳腺癌及其机制研究", 营养学报, 30(1), pp.57~60 (2008)
  34. 谷俊朝, "黄芪多糖对TA2小鼠乳腺癌MA-891移植瘤生长及HSP70表达的影响", 中华肿瘤防治杂志, 20(4), pp.1534~1537 (2006)
  35. 陈信义, "薯蓣皂苷抗移植性小鼠乳腺癌作用的研究", 中国中医药信息杂志, 12(5), pp.23~24 (2005)
  36. 陈前军, "乳宁Ⅱ号方对小鼠Ca761乳腺癌移植瘤细胞周期及p53和ras表达的影响", 中西医结合学报, 3(3), pp.225~228 (2005)
  37. 吴雪卿, "乳宁Ⅱ号对MCF-7移植瘤的抑瘤作用及对乳腺癌相关蛋白的影响", 中国中西医结合外科杂志, 10(2), pp.99~102 (2004)
  38. 沈健, "中药CY-1号对外源性雌激素致乳腺癌危险因素的阻断作用", 中国中西医结合杂志, 21, pp.128~130 (2001)
  39. 刘鹏, "参麦注射液促进乳腺癌患者术后恢复的临床观察", 中国中西医结合杂志, 20(5), pp.328~329 (2000)
  40. 代志军, "参芪扶正注射液在乳腺癌新辅助化疗中的疗效及不良反应的临床观察", 药物不良反应杂志, 9(1), pp.10~14 (2007)
  41. 陈芳, "参芪扶正注射液辅助乳癌化疗的疗效观察", 海峡药学, 19(12), pp.75~76 (2007)
  42. 黄智芬, "参芪扶正注射液联合化疗治疗晚期乳腺癌30例临床观察", 中国中西医结合杂志, 28(2), pp.152~154 (2008)
  43. 李洪胜, "中医扶正培本治疗对乳腺癌新辅助化疗患者免疫功能的影响", 临床肿瘤学杂志, 11(11), pp.851~857 (2006)
  44. 劳溢权, "苦参碱注射液预防乳腺癌化疗后肝功能损害效果观察", 中药材, 28(8), pp.735~737 (2005)
  45. 刘海涛, "苦参素注射液配合术后化疗治疗乳腺癌临床观察", 西部医学, 20(1), pp.96~97 (2008)
  46. 刘胜, "乳移平抗乳腺癌术后复发转移的临床研究", 中西医结合学报, 5(2), pp.147~149 (2007)
  47. 张瑾, "益气养血颗粒对绝经后乳腺癌患者内分泌功能的调节作用", 中国中西医结合外科杂志, 5(6), pp.335~337 (1999)
  48. 王怀璋, "中药配合化疗治疗晚期乳腺癌骨转移疼痛", 辽宁中医杂志, 28(40), pp.211~212 (2001)
  49. 梁少华, "升血和中汤防治乳腺癌术后化疗毒副反应临床观察", 广西中医药, 25(4), pp.8~12 (2002)
  50. 翁永强, "扶正祛邪法改善乳腺癌患者化疗毒副作用的临床观察", 上海中医药大学学报, 17(3), pp.28~31 (2003)
  51. 万华, "“乳癌术后方”对乳腺癌患者生活质量影响的临床研究", 上海中医药杂志, 38(9), pp.28~31 (2004)
  52. 程亦勤, "唐汉钧教授治疗乳腺癌手术后伤口不愈的经验", 中西医结合学报, 3(3), pp.238~239 (2005)
  53. 沈晔华, "中西医结合治疗71例乳腺癌术后患者的疗效分析", 中西医结合学报, 1(1), pp.30~31 (2003)
  54. 司徒红林, "中药癌复康对乳腺癌术后化疗患者生存质量的影响", 广州中医药大学学报, 22(1), pp.26~29 (2005)
  55. 李洪胜, "扶正培本法对乳腺癌患者树突状细胞的影响研究", 中药材, 34(7), pp.377~380 (2007)
  56. 闻小娟, "消肿散治乳腺癌60例临床观察", 辽宁中医杂志, 34(7), pp.909~910 (2007)
  57. 张莉, "扶正消瘤汤对乳腺癌患者生活质量的影响", 现代中西医结合杂志, 16(18), pp.2494~2573 (2007)
  58. Burdall SE, "Breast cancer cell lines, friend or foe?", Breast Cancer Research, 5(2), pp.89~95 (2003)
  59. Dickson RB, "Characterization of estrogen responsive transforming activity in human breast cancer cell lines", Cancer Res, 46(4), pp.1707~1713 (1986)
  60. Mukhopadhyay R, "Increased levels of alpha6 integrins are associated with the metastatic phenotype of human breast cancer cells", Clin Exp Metastasis, 17(4), pp.325~332 (1999)
  61. Thompson EW, "Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines", J Cell Physiol, 150, pp.534~544 (1992)
  62. Bai J, "Retroviral vector containing human p16 gene and its inhibitory effect on Bcap-37 breast cancer cells", Chin Med J, 114(5), pp.497~501 (2001)
  63. Biscardi JS, "Characterization of human epidermal growth factor receptor and c-Src interactions in human breast tumor cells", Mol Carcinog, 21(4), pp.261~272 (1998)
  64. Szöllösi J, "ERBB-2 (HER2", neu) gene copy number, p185HER-2 overexpression, and intratumor heterogeneity in human breast cancer, 1995, pp.55(22), 5400~5407
  65. Jadad AR, "Assessing the quality of reports of randomized clinical trials: is blinding necessary?", Controlled Clinical Trials, 17(1), pp.1~12 (1996)

관련 논문AI추천

유방암에 대한 국내 한의학 연구 동향 고찰- 국내 한의학 논문을 중심으로 -성신, 김성수, 손지영, 한가진대한한방내과학회 · 대한한방내과학회지2018 · 제39권 제1호유방암 치료에 대한 한의 임상 가이드라인 개발을 위한 기초연구유화승, 이강욱, 이남헌, 이진선대한한방부인과학회 · 대한한방부인과학회지2016 · 제29권 제2호국내에 보고된 한국 한의학의 암치료 임상연구에 대한 계통적 고찰박봉기, 신현규, 엄석기, 유화승, 이종훈, 조종관대한한방내과학회 · 대한한방내과학회지2008 · 제29권 제4호유방암의 보완대체의학적 치료에 관한 연구김동철, 박영애대한한방부인과학회 · 대한한방부인과학회지2009 · 제22권 제3호유방암에 대한 한양방 병용 치료 증례 보고 1례성신, 김성수, 이아람, 정준석, 한가진대한한방내과학회 · 대한한방내과학회지2017 · 제38권 제5호위암의 중의약 치료에 대한 문헌적 고찰곽민아, 서정철, 손기철, 정진형대한한방내과학회 · 대한한방내과학회지2014 · 제35권 제3호

이 간행물의 다른 논문 (19건)

人蔘養營湯의 산화적 stress에 대한 뇌세포 보호효과이창훈, 조정훈, 이경섭, 김승현, 이진무, 장준복pp. 1-14六鬱湯의 산화적 스트레스에 대한 뇌세포 보호효과조정훈, 장준복, 이창훈, 이경섭, 정선형, 이진무pp. 15-30桑白皮의 선천면역 활성화에 의한 항암 효과이창훈, 조정훈, 이경섭, 정재혁, 이진무, 장준복pp. 31-40免疫活性에 의한 夏枯草의 癌轉移 抑制 效果허자경, 이진무, 장준복, 이창훈, 조정훈, 이경섭pp. 41-52加味調經湯의 煎湯 방법에 따른 항혈전 및 염증에 관한 연구안규환, 최창민, 김송백, 조한백pp. 53-78
원문 보기